QT
ABEO icon

Quantbot Technologies’s Abeona Therapeutics ABEO Stock Holding History

Quantbot Technologies’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-128
Closed -$4K – 1464
2021
Q2 		$4K Buy
+128
New +$5.22K ﹤0.01% 1373
2018
Q4 		– Sell
-95
Closed -$30K – 987
2018
Q3 		$30K Buy
+95
New +$33.7K ﹤0.01% 1104

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Quantbot Technologies's ABEO Position: Q3 2021 in Review

Quantbot Technologies sold out of Abeona Therapeutics (ABEO) in Q3 2021, closing a stake of 128 shares — an estimated $4K sold.

Quantbot Technologies first reported a position in ABEO in Q3 2018 and held it in 2 quarters. The position peaked at $30K in Q3 2018. 58 funds tracked by Wall St. Rank hold ABEO as of Q3 2021.

  • Quantbot Technologies reported no remaining Abeona Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quantbot Technologies sold 128 Abeona Therapeutics shares in Q3 2021, an estimated $4K.
  • Quantbot Technologies first reported a position in Abeona Therapeutics in Q3 2018 and held it in 2 quarters.
  • Quantbot Technologies's Abeona Therapeutics position peaked at $30K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2021.

Based on Quantbot Technologies's 13F filing for Q3 2021, filed 9 Nov 2021.